Cargando…

Immunosuppressive niche engineering at the onset of human colorectal cancer

The evolutionary dynamics of tumor initiation remain undetermined, and the interplay between neoplastic cells and the immune system is hypothesized to be critical in transformation. Colorectal cancer (CRC) presents a unique opportunity to study the transition to malignancy as pre-cancers (adenomas)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatenbee, Chandler D., Baker, Ann-Marie, Schenck, Ryan O., Strobl, Maximilian, West, Jeffrey, Neves, Margarida P., Hasan, Sara Yakub, Lakatos, Eszter, Martinez, Pierre, Cross, William C. H., Jansen, Marnix, Rodriguez-Justo, Manuel, Whelan, Christopher J., Sottoriva, Andrea, Leedham, Simon, Robertson-Tessi, Mark, Graham, Trevor A., Anderson, Alexander R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979971/
https://www.ncbi.nlm.nih.gov/pubmed/35379804
http://dx.doi.org/10.1038/s41467-022-29027-8
_version_ 1784681294836269056
author Gatenbee, Chandler D.
Baker, Ann-Marie
Schenck, Ryan O.
Strobl, Maximilian
West, Jeffrey
Neves, Margarida P.
Hasan, Sara Yakub
Lakatos, Eszter
Martinez, Pierre
Cross, William C. H.
Jansen, Marnix
Rodriguez-Justo, Manuel
Whelan, Christopher J.
Sottoriva, Andrea
Leedham, Simon
Robertson-Tessi, Mark
Graham, Trevor A.
Anderson, Alexander R. A.
author_facet Gatenbee, Chandler D.
Baker, Ann-Marie
Schenck, Ryan O.
Strobl, Maximilian
West, Jeffrey
Neves, Margarida P.
Hasan, Sara Yakub
Lakatos, Eszter
Martinez, Pierre
Cross, William C. H.
Jansen, Marnix
Rodriguez-Justo, Manuel
Whelan, Christopher J.
Sottoriva, Andrea
Leedham, Simon
Robertson-Tessi, Mark
Graham, Trevor A.
Anderson, Alexander R. A.
author_sort Gatenbee, Chandler D.
collection PubMed
description The evolutionary dynamics of tumor initiation remain undetermined, and the interplay between neoplastic cells and the immune system is hypothesized to be critical in transformation. Colorectal cancer (CRC) presents a unique opportunity to study the transition to malignancy as pre-cancers (adenomas) and early-stage cancers are frequently resected. Here, we examine tumor-immune eco-evolutionary dynamics from pre-cancer to carcinoma using a computational model, ecological analysis of digital pathology data, and neoantigen prediction in 62 patient samples. Modeling predicted recruitment of immunosuppressive cells would be the most common driver of transformation. As predicted, ecological analysis reveals that progressed adenomas co-localized with immunosuppressive cells and cytokines, while benign adenomas co-localized with a mixed immune response. Carcinomas converge to a common immune “cold” ecology, relaxing selection against immunogenicity and high neoantigen burdens, with little evidence for PD-L1 overexpression driving tumor initiation. These findings suggest re-engineering the immunosuppressive niche may prove an effective immunotherapy in CRC.
format Online
Article
Text
id pubmed-8979971
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89799712022-04-20 Immunosuppressive niche engineering at the onset of human colorectal cancer Gatenbee, Chandler D. Baker, Ann-Marie Schenck, Ryan O. Strobl, Maximilian West, Jeffrey Neves, Margarida P. Hasan, Sara Yakub Lakatos, Eszter Martinez, Pierre Cross, William C. H. Jansen, Marnix Rodriguez-Justo, Manuel Whelan, Christopher J. Sottoriva, Andrea Leedham, Simon Robertson-Tessi, Mark Graham, Trevor A. Anderson, Alexander R. A. Nat Commun Article The evolutionary dynamics of tumor initiation remain undetermined, and the interplay between neoplastic cells and the immune system is hypothesized to be critical in transformation. Colorectal cancer (CRC) presents a unique opportunity to study the transition to malignancy as pre-cancers (adenomas) and early-stage cancers are frequently resected. Here, we examine tumor-immune eco-evolutionary dynamics from pre-cancer to carcinoma using a computational model, ecological analysis of digital pathology data, and neoantigen prediction in 62 patient samples. Modeling predicted recruitment of immunosuppressive cells would be the most common driver of transformation. As predicted, ecological analysis reveals that progressed adenomas co-localized with immunosuppressive cells and cytokines, while benign adenomas co-localized with a mixed immune response. Carcinomas converge to a common immune “cold” ecology, relaxing selection against immunogenicity and high neoantigen burdens, with little evidence for PD-L1 overexpression driving tumor initiation. These findings suggest re-engineering the immunosuppressive niche may prove an effective immunotherapy in CRC. Nature Publishing Group UK 2022-04-04 /pmc/articles/PMC8979971/ /pubmed/35379804 http://dx.doi.org/10.1038/s41467-022-29027-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Gatenbee, Chandler D.
Baker, Ann-Marie
Schenck, Ryan O.
Strobl, Maximilian
West, Jeffrey
Neves, Margarida P.
Hasan, Sara Yakub
Lakatos, Eszter
Martinez, Pierre
Cross, William C. H.
Jansen, Marnix
Rodriguez-Justo, Manuel
Whelan, Christopher J.
Sottoriva, Andrea
Leedham, Simon
Robertson-Tessi, Mark
Graham, Trevor A.
Anderson, Alexander R. A.
Immunosuppressive niche engineering at the onset of human colorectal cancer
title Immunosuppressive niche engineering at the onset of human colorectal cancer
title_full Immunosuppressive niche engineering at the onset of human colorectal cancer
title_fullStr Immunosuppressive niche engineering at the onset of human colorectal cancer
title_full_unstemmed Immunosuppressive niche engineering at the onset of human colorectal cancer
title_short Immunosuppressive niche engineering at the onset of human colorectal cancer
title_sort immunosuppressive niche engineering at the onset of human colorectal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979971/
https://www.ncbi.nlm.nih.gov/pubmed/35379804
http://dx.doi.org/10.1038/s41467-022-29027-8
work_keys_str_mv AT gatenbeechandlerd immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT bakerannmarie immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT schenckryano immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT stroblmaximilian immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT westjeffrey immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT nevesmargaridap immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT hasansarayakub immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT lakatoseszter immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT martinezpierre immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT crosswilliamch immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT jansenmarnix immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT rodriguezjustomanuel immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT whelanchristopherj immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT sottorivaandrea immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT leedhamsimon immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT robertsontessimark immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT grahamtrevora immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer
AT andersonalexanderra immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer